1. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (1488)
  2. Journal Article (1179)
  3. Review (70)
  4. Research Letter (46)
  5. Book Section (34)
  6. Guidelines (26)
  7. Editorial (23)
  8. Correspondence (17)
  9. Conference Paper (14)
  10. Book Whole (1)
  11. Miscellaneous (1)
Groups
  1. Bone Marrow Transplant (2899)
  2. Center for Hematologic Malignancies (2899)
  3. Department of Medicine (2899)
  4. Hematologic Malignancies, Division of (2776)
  5. Survivorship Research (1345)
  6. GSK Faculty (917)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Sean Devlin (457)
  4. Ann Jakubowski (456)
  5. Heather Landau (419)
  6. Gunjan Shah (418)

More People

Years
  1. 2025 (40)
  2. 2024 (169)
  3. 2023 (263)
  4. 2022 (201)
  5. 2021 (177)
  6. 2020 (208)

More Years

Publications
  1. Blood (840)
  2. Biology of Blood and Marrow Transplantation (516)
  3. Bone Marrow Transplantation (175)
  4. Journal of Clinical Oncology (125)
  5. Transplantation and Cellular Therapy (110)
  6. Blood Advances (88)

More Publications

Publishers
  1. American Society of Hematology (935)
  2. Elsevier Inc. (762)
  3. Nature Publishing Group (258)
  4. American Society of Clinical Oncology (127)
  5. Wiley Blackwell (65)
  6. Taylor & Francis Group (64)

More Publishers

Results (2899)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Effects of idecabtagene vicleucel (ide-cel) versus standard regimens on health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) who had received 2-4 prior regimens: Updated results from the phase 3 KarMMa-3 trial
    Meeting Abstract

    Delforge, M.; Patel, K. K.; Eliason, L.; Dhanda, D.; Shi, L.; Guo, S.; Marshall, T. S.; Arnulf, B.; Cavo, M.; Nooka, A. K.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Effects of idecabtagene vicleucel (ide-cel) versus standard regimens on health-related quality of life (HRQoL) in patients with triple-class-exposed (TCE) relapsed/refractory multiple myeloma (RRMM) who received at least 3 lines of prior antimyeloma regimens in the KarMMa-3 phase 3 randomized controlled trial
    Meeting Abstract

    Delforge, M.; Patel, K. K.; Eliason, L.; Dhanda, D.; Shi, L.; Guo, S.; Marshall, T. S.; Arnulf, B.; Cavo, M.; Nooka, A. K.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • PD-1 blockade before autologous stem cell transplantation improves outcomes in relapsed/refractory classic Hodgkin lymphoma: Results from a multicenter cohort
    Meeting Abstract

    Desai, S. H.; Merryman, R. W.; Shah, H.; Pederson, L. D.; Geyer, S. M.; Ganesan, N.; Chang, T.; Othman, T.; Falade, A. S.; Shah, G. L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Lisocabtagene Maraleucel in Relapsed/Refractory Large B-Cell LyLisocabtagene maraleucel in relapsed/refractory large B-cell lymphoma: Real world analysis from the Cell Therapy Consortiummphoma: Real World Analysis from the Cell Therapy Consortium
    Meeting Abstract

    Riedell, P. A.; Grady, C.; Nastoupil, L. J.; Luna, A.; Ahmed, N.; Maziarz, R. T.; Hu, M.; Brower, J.; Hwang, W. T.; Schuster, S. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Real-world outcomes of brexucabtagene autoleucel ( brexu-cel) for relapsed or refractory (R/R) adult B-cell acute lymphoblastic leukemia (B-cell ALL): Evidence from the CIBMTR registry
    Meeting Abstract

    Bezerra, E.; Itani, T.; Wudhikarn, K.; Perales, M. A.; Yang, Y.; Gergis, U.; Aribi, A.; Hill, L. C.; Jain, N.; Leonard, J. T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • SHLA-DRB1 HED is associated with improved survival and decreased relapse in patients with hematologic malignancies following allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Camacho-Bydume, C.; Wang, T.; Chowell, D.; Krishna, C.; Shaffer, B. C.; Marsh, S.; Paczesny, S.; Gadalla, S. M.; He, M.; Bolon, Y. T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • IL-33 induces Paneth cell production of EGF and soluble ST2, regulating epithelial regeneration after intestinal injury
    Meeting Abstract

    Calafiore, M.; Fu, Y. Y.; Vinci, P.; Arnhold, V.; Chang, W.; Jansen, S.; Egorova, A.; Takashima, S.; Kuttiyara, J.; Ito, T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of investigational microbiome therapeutic SER-155 on pathogen domination: Initial results from a phase 1b study in adults undergoing allogeneic hematopoietic cell transplantation (HCT)
    Meeting Abstract

    Peled, J. U.; van den Brink, M. R. M.; Ponce, D. M.; Kosuri, S.; Khera, N.; DeFilipp, Z.; Tejura, B.; Lichter, D. I.; Lombardo, M. J.; Wortman, J. R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Rabbit antithymocyte (rATG) exposure and outcomes after hematopoietic cell transplantation: A real world experience from BMT CTN 1202
    Meeting Abstract

    Lakkaraja, M.; Mauguen, A.; Hosszu, K. K.; McAvoy, D.; Stewart, V.; Schmidt, G.; Levine, J.; Perales, M. A.; Giralt, S. A.; Baker, K. S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes in mantle cell lymphoma with central nervous system involvement - A dual center study
    Meeting Abstract

    McLaughlin, N.; Joseph, A.; Wang, Y. C.; Pederson, L. D.; Geyer, S. M.; Witzig, T. E.; Zelenetz, A. D.; Villasboas, J. C. C.; Scordo, M.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save